GET DAILY SIGNALSCLVT vs XRX: Clarivate and Xerox Navigating Distinct Turnaround Paths
Key Takeaways
- Both CLVT and XRX are deep-value turnaround stories trading at depressed valuations, but their recent trajectories have diverged sharply.
- Tickeron AI Verdict: CLVT is the favored ticker in this comparison, supported by more consistent recurring-revenue trends and clearer AI-led catalysts.
- CLVT (Clarivate Plc) is pivoting toward a focused, subscription-heavy data and analytics business, while XRX (Xerox Holdings) is contending with intensifying cost headwinds and a dividend suspension.
- XRX delivered a wider net loss and cut its full-year profit and cash-flow guidance, triggering a sharp single-day sell-off in recent trading.
- Explore more on each ticker: CLVT Major News and CLVT Today's Price Move, plus XRX Major News and XRX Today's Price Move.
- To see how algorithmic strategies are positioning across thousands of tickers, explore Trending AI Robots.
Setting the Stage for Two Value Stories
This comparison highlights two established companies at key points in their transformations. CLVT (Clarivate Plc) provides data, analytics, and workflow solutions for academia, government, and intellectual property. XRX (Xerox Holdings) focuses on document technology and IT services amid a challenging print market. Both carry significant debt, trade well below historical levels, and are working to stabilize revenue while lifting profitability. In my view, investors tracking relative performance may find the contrast instructive, as the companies face similar pressures yet show quite different progress.
CLVT Overview and Recent Performance
CLVT has been streamlining its operations. It completed the sale of its Life Sciences & Healthcare segment ahead of schedule, resulting in a more focused business in Academia & Government and Intellectual Property, with about 93% of revenue recurring. In the latest quarter, continuing-operations revenue reached roughly $482 million, and adjusted EPS of $0.21 beat consensus estimates. Recurring organic revenue returned to growth, and intellectual-property annual contract value turned positive for the first time in more than three years. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Sentiment remains cautious due to slower transactional revenue, modest total organic growth, and net debt around $4.2 billion. Management reduced full-year growth and free-cash-flow targets, though margin expansion and debt reduction have continued. The stock has declined materially over the past 12 months, but recent quarters show sequential gains in key indicators. New AI-led products such as the IPOne platform and Web of Science Research Intelligence are positioned as longer-term catalysts.
XRX Overview and Recent Performance
XRX is integrating its Lexmark acquisition while dealing with a shrinking print market and a developing IT Solutions business. In the most recent quarter, revenue fell about 4.7% year over year to roughly $1.87 billion, adjusted operating margin rose to 6.6%, and equipment revenue returned to growth for the first time in several years. These positives were overshadowed by a net loss of about $1.02 billion, largely from a non-cash goodwill impairment of roughly $955 million.
The company lowered full-year adjusted operating income guidance to $450–$475 million from $555–$605 million and cut free-cash-flow outlook to $50–$100 million from about $250 million. Management pointed to higher memory and oil costs, a shift toward lower-margin devices, and weaker IT Solutions results. The board suspended common and preferred dividends to conserve cash, and leverage stays elevated. The stock fell sharply in recent trading as investors reassessed the balance-sheet pressure.
Head-to-Head Comparison
The companies operate in different sectors with distinct growth drivers. CLVT is in software and information services, where high subscription revenue offers visibility and AI can enhance its data and workflow offerings. XRX is in a hardware-intensive, secularly declining print industry, where AI spending is moving away from physical infrastructure—a challenge its management has noted.
Performance trends also differ. CLVT shows gradual improvement in recurring growth and ACV, even as overall growth stays modest. XRX is expanding margins and equipment sales but has cut guidance and suspended its dividend, signaling near-term strain. Risk profiles are similar in leverage, yet XRX has a thinner cash-flow buffer and greater exposure to input-cost inflation and product-mix shifts. From a positioning standpoint, CLVT presents a clearer path to recurring-revenue stability, while XRX faces a more execution-dependent restructuring.
Tickeron AI Verdict
Based on the factors observed, Tickeron’s AI currently favors CLVT in this matchup. The company’s improving recurring-revenue path, returning IP ACV growth, AI-aligned product pipeline, and continued debt reduction provide more consistent signals. By contrast, XRX is handling rising cost pressures, guidance reductions, a dividend suspension, and a large goodwill impairment, pointing to greater near-term uncertainty. The assessment reflects relative positioning and trend consistency rather than a firm prediction.
Using Tickeron’s Trending AI Robots for Market Context
In my own research process, I often turn to Tickeron’s curated selection of AI trading bots to understand how different strategies are positioned across thousands of tickers. The Trending AI Robots section highlights the best-performing approaches for current conditions, spanning momentum, trend, and mean-reversion styles with clear performance data. This helps me quickly compare automated models without reviewing the entire library, offering a practical way to align strategies with market realities like those affecting turnaround names.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Momentum Indicator for CLVT turns negative, indicating new downward trend
CLVT saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In 77 of the 84 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
CLVT moved below its 50-day moving average on October 27, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for CLVT entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CLVT's RSI Oscillator exited the oversold zone, 32 of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for CLVT just turned positive on October 13, 2026. Looking at past instances where CLVT's MACD turned positive, the stock continued to rise in 37 of 46 cases over the following month. The odds of a continued upward trend are 80%.
Following a +6.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where CLVT advanced for three days, in 161 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
CLVT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 26 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.234) is normal, around the industry mean (2.802). P/E Ratio (-3.192) is within average values for comparable stocks, (18.164). Projected Growth (PEG Ratio) (0.178) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.195) among similar stocks. P/S Ratio (0.504) is also within normal values, averaging (139.965).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. CLVT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a maker of activated carbon and related products and systems
Industry InformationTechnologyServices
Advertisement